x

We are happy to announce that all trial registrations will now be issued DOIs (digital object identifiers). For more information, see here.
Mental Health, Productivity, and Child Investment in Peri-Urban Bangalore
Last registered on May 06, 2019

Pre-Trial

Trial Information
General Information
Title
Mental Health, Productivity, and Child Investment in Peri-Urban Bangalore
RCT ID
AEARCTR-0001067
Initial registration date
February 19, 2016
Last updated
May 06, 2019 5:34 PM EDT
Location(s)
Region
Primary Investigator
Affiliation
University of Southern California
Other Primary Investigator(s)
PI Affiliation
Shridevi Institute of Medical Sciences and Research Hospital
PI Affiliation
University of Michigan
Additional Trial Information
Status
Completed
Start date
2016-11-01
End date
2018-11-01
Secondary IDs
Abstract
This study evaluates a community intervention to facilitate depression treatment and provide economic assistance to women in peri-urban communities near Bangalore. Participants in the intervention receive depression treatment and placement and employment opportunities. We randomize these components in a “two-by-two” design, which will allow us to assess the impact of depression treatment and economic assistance both separately and jointly. We will measure impacts on mental health, time use, risk and time preferences, and child investment over four and eight months.
External Link(s)
Registration Citation
Citation
Angelucci, Manuela, Anil B.N. and Daniel Bennett. 2019. "Mental Health, Productivity, and Child Investment in Peri-Urban Bangalore." AEA RCT Registry. May 06. https://doi.org/10.1257/rct.1067-3.0.
Former Citation
Angelucci, Manuela, Anil B.N. and Daniel Bennett. 2019. "Mental Health, Productivity, and Child Investment in Peri-Urban Bangalore." AEA RCT Registry. May 06. https://www.socialscienceregistry.org/trials/1067/history/46014.
Experimental Details
Interventions
Intervention(s)
The community intervention includes two key components: depression treatment and job placement assistance.

a. Facilitated depression treatment. Although free mental health care is available to everyone in the sample, we will encourage participants in these treatment arms to seek care. GASS will arrange additional mental health camps for these arms. They will provide transportation to and from the taluk hospital, and they will coordinate with the hospital and pharmacies to ensure that patients receive their medicine. For GASS-organized camps, GASS will contract privately with up three local psychiatrists (with whom it has ongoing relationships) to provide care for these participants. As appropriate, psychiatrists may prescribe one of the following off-patent SSRI medications: citalopram,escitalopram, fluoxetine, paroxetine, or sertraline. GASS will also arrange for monthly follow-up visits with psychiatrists in order to monitor patient reactions and monitor dosages.

b. Job placement assistance. GASS will provide job placement services to participants. There are several dozen factories in the area, including plants making garments, cement, plastics, medicine, wristwatches, paint, and cosmetics. GASS is highly networked with these employers, having successfully placed 241 people (typically with more severe physical and mental disabilities) in 2014 through its normal program activities.
Intervention Start Date
2016-12-01
Intervention End Date
2018-09-01
Primary Outcomes
Primary Outcomes (end points)
Mental health
Time use
Child investment
Primary Outcomes (explanation)
Secondary Outcomes
Secondary Outcomes (end points)
Secondary Outcomes (explanation)
Experimental Design
Experimental Design
We will randomize participants across treatment arms in a two-by-two design, as shown below. Group A will receive facilitated depression treatment and job placement assistance. Group B will receive only job placement assistance. Group C will receive only facilitated depression treatment. Group D will not receive either program but will receive monthly depression monitoring by GASS.
Experimental Design Details
Randomization Method
Computer
Randomization Unit
We will randomize participants by village across these arms to reduce the risk that participants will learn about the differences in treatment across study arms.
Was the treatment clustered?
Yes
Experiment Characteristics
Sample size: planned number of clusters
750 villages
Sample size: planned number of observations
1500 participants
Sample size (or number of clusters) by treatment arms
300 receive depression treatment and livelihoods support
300 receive depression treatment
300 receive livelihoods support
600 receive depression monitoring
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Supporting Documents and Materials

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information
IRB
INSTITUTIONAL REVIEW BOARDS (IRBs)
IRB Name
IFMR Human Subjects Committee
IRB Approval Date
2015-08-31
IRB Approval Number
NA
IRB Name
Shridevi Institute of Medical Sciences and Research Hospital
IRB Approval Date
2016-12-16
IRB Approval Number
NA
IRB Name
University of Chicago BSD IRB
IRB Approval Date
2016-02-01
IRB Approval Number
IRB15-1085
Analysis Plan

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information
Post-Trial
Post Trial Information
Study Withdrawal
Intervention
Is the intervention completed?
Yes
Intervention Completion Date
December 31, 2017, 12:00 AM +00:00
Is data collection complete?
No
Data Publication
Data Publication
Is public data available?
No
Program Files
Program Files
No
Reports and Papers
Preliminary Reports
Relevant Papers